{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:09:17Z","timestamp":1778479757114,"version":"3.51.4"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Severe Cushing\u2019s syndrome (SCS) is a rare but potentially fatal endocrine emergency. We describe a woman in her fifties with a history of pituitary macroadenoma who presented with mood disturbance, proximal muscle weakness, and Cushingoid features. On admission to the intensive care unit (ICU) she was febrile, hypoxic, hypotensive, and disoriented, with imaging prior confirming recurrent pituitary macroadenoma and biochemical tests showing severe hypercortisolism. She was managed with intravenous etomidate, starting with a bolus followed by titrated infusion, which achieved rapid cortisol suppression. A block-and-replace strategy was then implemented, introducing physiological hydrocortisone once cortisol levels fell to the target range. Broad spectrum antimicrobial therapy and organ support were provided. Although biochemical control was achieved, her course was complicated by ventilator-associated pneumonia with multidrug-resistant organisms, culminating in refractory septic shock and death. This case underlines the diagnostic challenges of recognizing SCS in sepsis and the clinical value of etomidate-based block-and-replace therapy.<\/jats:p>","DOI":"10.3389\/fmed.2026.1817935","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:29:09Z","timestamp":1778477349000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Navigating the complexities of severe Cushing\u2019s syndrome in the ICU: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Kunchala","family":"Anand","sequence":"first","affiliation":[{"name":"Sri Ramachandra Institute of Higher Education and Research","place":["Chennai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Velmurugan","family":"Selvam","sequence":"additional","affiliation":[{"name":"Sri Ramachandra Institute of Higher Education and Research","place":["Chennai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. K.","family":"Renuka","sequence":"additional","affiliation":[{"name":"Sri Ramachandra Institute of Higher Education and Research","place":["Chennai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome.","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing\u2019s syndrome.","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","article-title":"Cushing\u2019s syndrome.","volume":"402","author":"Gadelha","year":"2023","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1530\/EJE-19-0464","article-title":"High mortality within 90 days of diagnosis in patients with Cushing\u2019s syndrome: results from the ERCUSYN registry.","volume":"181","author":"Valassi","year":"2019","journal-title":"Eur J Endocrinol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1586\/17446651.2016.1123615","article-title":"Current strategies for the treatment of severe Cushing\u2019s syndrome.","volume":"11","author":"Alexandraki","year":"2016","journal-title":"Exp Rev Endocrinol Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12020-016-0984-8","article-title":"Cushing\u2019s disease: the burden of illness.","volume":"56","author":"Pivonello","year":"2017","journal-title":"Endocrine."},{"key":"B7","doi-asserted-by":"publisher","first-page":"20420188211058583","DOI":"10.1177\/20420188211058583","article-title":"Pharmacological management of severe Cushing\u2019s syndrome: the role of etomidate.","volume":"13","author":"Pence","year":"2022","journal-title":"Therapeutic Adv Endocrinol Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline.","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"bvaf039","DOI":"10.1210\/jendso\/bvaf039","article-title":"Etomidate in severe cushing syndrome: a systematic review.","volume":"9","author":"Muthukuda","year":"2025","journal-title":"J Endocrine Soc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"101487","DOI":"10.1016\/j.beem.2021.101487","article-title":"Medical therapy in severe hypercortisolism. best practice & research.","volume":"35","author":"Marques","year":"2021","journal-title":"Clin Endocrinol Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"dgz136","DOI":"10.1210\/clinem\/dgz136","article-title":"Time to diagnosis in cushing\u2019s syndrome: a meta-analysis based on 5367 Patients.","volume":"105","author":"Rubinstein","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-19-0044","article-title":"Etomidate in the management of severe Cushing\u2019s disease and MRSA bacteraemia in a district general hospital in the United Kingdom.","author":"Wong","year":"2019","journal-title":"Endocrinol Diab Metab Case Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1530\/eje-12-0274","article-title":"Etomidate in the management of hypercortisolaemia in Cushing\u2019s syndrome: a review.","volume":"167","author":"Preda","year":"2012","journal-title":"Eur J Endocrinol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.5005\/ijccr-4-S1-S1","article-title":"Navigating the complexities of acute Cushing\u2019s syndrome in the ICU.","volume":"4","author":"Anand","year":"2025","journal-title":"Case Rep Crit Care."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1817935\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:29:10Z","timestamp":1778477350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1817935\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":14,"alternative-id":["10.3389\/fmed.2026.1817935"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1817935","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"article-number":"1817935"}}